2 completed, 1 recruiting. 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow Acyclovir (ACV): new trials by email Literature Review of Acyclovir (ACV) trials Research Report on Acyclovir (ACV)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prevention of Recurrence of Herpes Simplex in Autoimmune Rheumatic Diseases Acyclovir (ACV), Placebo - Autoimmune Rheumatic Diseases, Recurrent Herpes Simplex | Phase 4 | Recruiting | University of Sao Paulo General Hospital | 62 | 2026-06-25 | 2026-08-05 |
| Letermovir Versus Valganciclovir to Prevent Human Cytomegalovirus Disease in Kidney Transplant Recipients (MK-8228-002) Letermovir, Valganciclovir, Acyclovir (ACV) - CMV Disease | Phase 3 | Completed | Merck Sharp & Dohme LLC | 601 | 2018-05-03 | 2023-07-28 |
| Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212) Acyclovir (ACV) - Ulcer, Herpes Genitalis | Phase 2 | Completed | French National Agency for Research on AIDS and Viral Hepatitis | 449 | 2003-05-01 | 2008-12-30 |
Herpes Genitalis (1) · Herpes Simplex (1) · Ulcer (1)
French National Agency for Research on AIDS and Viral Hepatitis (1) · Merck Sharp & Dohme LLC (1) · University of Sao Paulo General Hospital (1)
Argentina (1) · Australia (1) · Austria (1) · Belgium (1) · Brazil (1) · Canada (1) · Central African Republic (1) · Colombia (1) · France (1) · Germany (1) · Ghana (1) · Hungary (1) · Italy (1) · Mexico (1) · New Zealand (1)
Laurent Belec (1) · Philippe Mayaud (1)
PMID 19530940, PMID 37279999, PMID 38700045, PMID 38853607, PMID 41321121, PMID 42639594
2017 (1)